Johnson & Johnson (JNJ) FY2026 Q2 Balance Sheet

Johnson & Johnson (JNJ) FY2026 Q2 Balance Sheet

Balance sheet as of 2026-06-28. The chart shows assets, liabilities and equity at that date.

Assets

201,061,000,000 US dollars

Current assets

59,774,000,000 US dollars

Non-current assets

141,287,000,000 US dollars

Liabilities

116,090,000,000 US dollars

Current liabilities

54,895,000,000 US dollars

Non-current liabilities

61,195,000,000 US dollars

Equity

84,971,000,000 US dollars

Property, plant and equipment at cost

55,518,000,000 US dollars. Part of Property, plant and equipment, net, drawn as one net amount.

Less: accumulated depreciation

negative 31,936,000,000 US dollars. Part of Property, plant and equipment, net, drawn as one net amount.

Cash and cash equivalents (Note 4)

20,422,000,000 US dollars

Accounts receivable, trade, less allowances $171 (2025, $183)

19,046,000,000 US dollars

Inventories (Note 2)

15,144,000,000 US dollars

Prepaid expenses and other

4,826,000,000 US dollars

Marketable securities

336,000,000 US dollars

Goodwill (Note 3)

48,479,000,000 US dollars

Intangible assets, net (Note 3)

48,229,000,000 US dollars

Property, plant and equipment, net

23,582,000,000 US dollars

Other assets

14,269,000,000 US dollars

Deferred taxes on income (Note 5)

6,728,000,000 US dollars

Accrued rebates, returns and promotions

19,990,000,000 US dollars

Loans and notes payable

11,692,000,000 US dollars

Accrued liabilities

9,464,000,000 US dollars

Accounts payable

9,223,000,000 US dollars

Accrued compensation and employee related obligations

3,475,000,000 US dollars

Accrued taxes on income (Note 5)

1,051,000,000 US dollars

Long-term debt (Note 4)

37,344,000,000 US dollars

Other liabilities

10,101,000,000 US dollars

Employee related obligations (Note 6)

6,657,000,000 US dollars

Deferred taxes on income (Note 5)

6,608,000,000 US dollars

Long-term taxes payable (Note 5)

485,000,000 US dollars

Retained earnings and Additional paid-in capital

171,665,000,000 US dollars

Common stock — par value $1.00 per share (authorized 4,320,000,000 shares; issued 3,119,843,000 shares)

3,120,000,000 US dollars

Less: common stock held in treasury, at cost (711,615,000 and 711,904,000 shares)

negative 75,863,000,000 US dollars

Accumulated other comprehensive income (loss) (Note 7)

negative 13,951,000,000 US dollars

Gross equity (calculated)

174,785,000,000 US dollars. Net equity plus the magnitudes of its negative contributions equals gross positive equity. The negative contributions enter this reconciliation as add-backs; their filed signs stay negative.

Chart connections

• Assets equal liabilities plus consolidated equity. Consolidated equity includes noncontrolling interests when reported.
• Treasury shares and other negative equity contributions reduce equity.